Key result
The cloning of voltage-activated K+ channels provides new insights into the molecular architecture and pharmacological mechanisms of cardiac K+ channel proteins.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Offers molecular insights into cardiac K+ channels; leaves open clinical translation pending functional validation.
The recent cloning of numerous voltage-activated K+ channels provides new information concerning the architecture of K+ channel proteins. The combination of molecular genetic and biophysical methods gives us a new insight into the molecular mechanisms of K+ channel pharmacology.
No takes yet. Share an insight, caveat, or question.
Honoré et al. (1994) studied this question. The cloning of voltage-activated K+ channels provides new insights into the molecular architecture and pharmacological mechanisms of cardiac K+ channel proteins.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: